Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease
Main Author: | Björn Spittau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=9;spage=1433;epage=1434;aulast=Spittau |
Similar Items
-
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson’s Disease-Lessons from Transgenic Mice
by: Venissa Machado, et al.
Published: (2016-01-01) -
Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01) -
Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
by: Laura Hühner, et al.
Published: (2017-03-01) -
Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
by: Seulah Lee, et al.
Published: (2021-02-01) -
Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease
by: Yaozhen Wang, et al.
Published: (2018-09-01)